Article

Expression and prognostic value of hsa-miR-206 in non-triple-negative breast cancer

2024-06-17

Abstract excerpt

<title>Abstract</title> <p><bold>Objective</bold> This study aims to analyze the expression and prognostic value of hsa-miR-206 in non-triple-negative breast cancer. <bold>Methods</bold> The expression of has-miR-206 in breast cancer and normal breast tissues was analyzed using the dbDEMC 2.0 database. The TCGA dataset was used to verify hsa-miR-206 expression and analyze its role in breast cancer pathways. In si...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 44ff44c0-e206-5144-ad5c-99ca6e4cea5c
DOI: 10.21203/rs.3.rs-4507297/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Expression and prognostic value of hsa-miR-206 in non-triple-negative breast cancerDOI 10.21203/rs.3.rs-4507297/v1Read

Downregulation of Hsa-miR-3616-3p in Triple-Negative Breast Cancer is Associated with Cell Migration and InvasionSemantic proximity Read

Comprehensive analysis of negatively correlated miRNA-mRNA regulatory pairs associated with breast cancer diagnosisSemantic proximity Read

The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells.Semantic proximity Read

High Expression of miR-206 Predicts Adverse Outcomes: A Potential Therapeutic Target for Esophageal CancerSemantic proximity Read

Hsa-mir-210 as a novel signature predicts survival in lung squamous cell carcinoma using bioinformatics analysisSemantic proximity Read

Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes.Semantic proximity Read

Integrative analysis of mRNA and miRNA proﬁles identifies miR-193 and miR-210 as potential regulatory biomarkers in diﬀerent molecular subtypes of breast cancerSemantic proximity Read

The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines.Semantic proximity Read

A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancerSemantic proximity Read

The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancerSemantic proximity Read

BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer.Semantic proximity Read

MiR-218-5p promotes breast cancer progression via LRIG1Semantic proximity Read